Dietary resistant starch increases hypothalamic POMC expression in rats

Obesity

Volumn 17, Issue 1, 2009, Pages 40-45

  Shen, Li ^a,b   Keenan, Michael J ^b   Martin, Roy J ^a,b   Tulley, Richard T ^b   Raggio, Anne M ^a,b   McCutcheon, Kathleen L ^b   Zhou, Jun ^a,b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; CAPSAICIN; CHOLECYSTOKININ; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY; PROOPIOMELANOCORTIN;

ANIMAL; ANIMAL FOOD; ARTICLE; BLOOD; BODY WEIGHT; CALORIC INTAKE; DIETARY FIBER; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HYPOTHALAMUS; MALE; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

AGOUTI-RELATED PROTEIN; ANIMAL FEED; ANIMALS; BODY WEIGHT; CAPSAICIN; CHOLECYSTOKININ; DIETARY FIBER; ENERGY INTAKE; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; HYPOTHALAMUS; MALE; PEPTIDE YY; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY;

AGOUTI; RATTUS;

EID: 57949107011     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.483     Document Type: Article

References (41)

1. Brown IL. Applications and uses of Resistant Starch. J AOAC Int 2004;87:727-732.
2. Higgins JA. Resistant starch: metabolic effects and potential health benefits. J AOAC Int 2004;87:761-768.
3. Achour L, Flourie B, Briet F et al. Metabolic effects of digestible and partially indigestible cornstarch: a study in the absorptive and postabsorptive periods in healthy humans. Am J Clin Nutr 1997;66:1151-1159.
4. Liljeberg HG, Akerberg AK, Bjorck IM. Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. Am J Clin Nutr 1999;69: 647-655.
5. Raben A, Tagliabue A, Christensen NJ et al. Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety. Am J Clin Nutr 1994;60:544-551.
6. de Roos N, Heijnen ML, de Graaf C, Woestenenk G, Hobbel E. Resistant starch has little effect on appetite, food intake and insulin secretion of healthy young men. Eur J Clin Nutr 1995;49:532-541.
7. Garcia TA, McCutcheon KL, Francis AR et al. The effects of Resistant Starch on gastrointestinal organs and fecal output in rats. FASEB J 2003;17:A335.
8. Hegsted M, Francis AR, McCutcheon KL et al. Amylose Resistant Starch (RS) decreases body fat in rats. FASEB J 2003;17:A335.
9. Keenan MJ, Zhou J, McCutcheon KL et al. Effects of Resistant Starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 2006;14:1523-1534.
10. Zhou J, Hegsted M, McCutcheon KL et al. Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring) 2006;14:683-689.
11. Murphy KG, Dhillo WS, Bloom SR. Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev 2006;27:719-727.
12. Young AA. Obesity: a peptide YY-deficient, but not peptide YY-resistant, state. Endocrinology 2006;147:1-2.
13. Batterham RL, Cowley MA, Small CJ et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002;418:650-654.
14. Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3: 153-165.
15. Neary NM, Small CJ, Druce MR et al. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005;146: 5120-5127.
16. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology 2007;132:2116-2130.
17. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-671.
18. Cone RD, Cowley MA, Butler AA et al. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 2001;25(Suppl 5):S63-S67.
19. Riediger T, Bothe C, Becskei C, Lutz TA. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Neuroendocrinology 2004;79:317-326.
20. Acuna-Goycolea C, van den Pol AN. Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J Neurosci 2005;25:10510-10519.
21. Larsen PJ, Tang-Christensen M, Jessop DS. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 1997;138:4445-4455.
22. Ghamari-Langroudi M, Colmers WF, Cone RD. PYY3-36 inhibits the action potential firing activity of POMC neurons of arcuate nucleus through postsynaptic Y2 receptors. Cell Metab 2005;2:191-199.
23. Challis BG, Pinnock SB, Coll AP et al. Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 2003;311:915-919.
24. Abbott CR, Monteiro M, Small CJ et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005;1044:127-131.
25. Koda S, Date Y, Murakami N et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 2005;146: 2369-2375.
26. Osaka T, Endo M, Yamakawa M, Inoue S. Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system. Peptides 2005;26:1623-1631.
27. So PW, Yu WS, Kuo YT et al. Impact of Resistant Starch on body fat patterning and central appetite regulation. PLoS ONE 2007;2:e1309.
28. Kelly L, Morales S, Smith BK, Berthoud HR. Capsaicin-treated rats permanently overingest low- but not high-concentration sucrose solutions. Am J Physiol Regul Integr Comp Physiol 2000;279:R1805-R1812.
29. Palkovits MAB, Michael J. Maps and Guide to Microdissection of the Rat Brain. Elsevier Science Publishing Company: New York, 1988.
30. Morrison CD, Xi X, White CL, Ye J, Martin RJ. Amino acids inhibit Agrp gene expression via an mTOR-dependent mechanism. Am J Physiol Endocrinol Metab 2007;293:E165-E171.
31. Ritter S, Taylor JS. Capsaicin abolishes lipoprivic but not glucoprivic feeding in rats. Am J Physiol 1989;256:R1232-R1239.
32. Ritter S, Dinh TT. Capsaicin-induced neuronal degeneration: silver impregnation of cell bodies, axons, and terminals in the central nervous system of the adult rat. J Comp Neurol 1988;271:79-90.
33. Phillips RJ, Powley TL. Tension and stretch receptors in gastrointestinal smooth muscle: re-evaluating vagal mechanoreceptor electrophysiology. Brain Res Brain Res Rev 2000;34:1-26.
34. Baggio LL, Drucker DJ. Biology of Incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-2157.
35. Batterham RL, Cohen MA, Ellis SM et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003;349: 941-948.
36. Ballantyne GH. Peptide YY(1-36) and peptide YY(3-36): part I. distribution, release and actions. Obes Surg 2006;16:651-658.
37. Koda S, Date Y, Murakami N et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 2005;146: 2369-2375.
38. Nakagawa A, Satake H, Nakabayashi H et al. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci 2004; 110:36-43.
39. Ma X, Bruning J, Ashcroft FM. Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons. J Neurosci 2007;27: 7125-7129.
40. Challis BG, Coll AP, Yeo GS et al. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc Natl Acad Sci USA 2004;101: 4695-4700.
41. Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 1999;403:261-280.